Protein kinase C delta type
Also known as: PRKCD
Function
Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression, is required for oxygen radical production by NADPH oxidase and acts as a positive or negative regulator in platelet functional responses. Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis. In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53. In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53. In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation. Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1. Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways. Involved in antifungal immunity by mediating phosphorylation and activation of CARD9 downstream of C-type lectin receptors activation, promoting interaction between CARD9 and BCL10, followed by activation of NF-kappa-B and MAP kinase p38 pathways (By similarity). May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA. In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation. Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release. Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin (By similarity). The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion. Phosphorylates ELAVL1 in response to angiotensin-2 treatment (By similarity). Phosphorylates mitochondrial phospholipid scramblase 3 (PLSCR3), resulting in increased cardiolipin expression on the mitochondrial outer membrane which facilitates apoptosis (By similarity). Phosphorylates SMPD1 which induces SMPD1 secretion (By similarity). Acts as a negative regulator of smoothened signaling by mediating phosphorylation of GLI1, preventing its localization to the nucleus (By similarity).
Classification
- Family (Pfam)
- PF00130 C1_1, PF21494 PKC_C2, PF00069 Pkinase, PF00433 Pkinase_C
- InterPro
- AGC-kinase_C, C1-like_sf, C2_dom, C2_domain_sf, DAG/PE-bd, Kinase-like_dom_sf, PKC_DAG/PE, PKC_delta, Pkinase_C, Prot_kin_PKC_delta, Prot_kinase_dom, Protein_kinase_ATP_BS, Ser/Thr_kinase_AS
- Functional cluster
- Serine/Threonine Protein Kinases
Gene Ontology · 27
- GO:0005737 cytoplasm
- GO:0005829 cytosol
- GO:0036019 endolysosome
- GO:0005783 endoplasmic reticulum
- GO:0005739 mitochondrion
- GO:0005634 nucleus
- GO:0048471 perinuclear region of cytoplasm
- GO:0005886 plasma membrane
- GO:0005524 ATP binding
- GO:0004699 diacylglycerol-dependent, calcium-independent serine/threonine kinase activity
- GO:0004715 non-membrane spanning protein tyrosine kinase activity
- GO:0106310 protein serine kinase activity
- GO:0004674 protein serine/threonine kinase activity
- GO:0008270 zinc ion binding
- GO:0006915 apoptotic process
- GO:1904385 cellular response to angiotensin
- GO:0034644 cellular response to UV
- GO:0042742 defense response to bacterium
- GO:0035556 intracellular signal transduction
- GO:0030837 negative regulation of actin filament polymerization
- GO:0051490 negative regulation of filopodium assembly
- GO:0034351 negative regulation of glial cell apoptotic process
- GO:0090331 negative regulation of platelet aggregation
- GO:0018105 peptidyl-serine phosphorylation
- GO:0032930 positive regulation of superoxide anion generation
- GO:0006468 protein phosphorylation
- GO:2000303 regulation of ceramide biosynthetic process
Drugs targeting this protein · 1
- TIGILANOL TIGLATE activator
Related proteins · sequence + function similarity
- Protein kinase C delta type 0.99
- Protein kinase C delta type 0.99
- Protein kinase C delta type 0.99
- Protein kinase C theta type 0.94
- Protein kinase C theta type 0.94
- Protein kinase C theta type 0.94
- Protein kinase C-like 1 0.93
- Protein kinase C-like 2 0.92
- Protein kinase C epsilon type 0.92
- Protein kinase C epsilon type 0.92
- Protein kinase C epsilon type 0.91
- Calcium-independent protein kinase C 0.91